Seyffert, J. and Steffes, W. (2019) “Vitiligo following alemtuzumab therapy in multiple sclerosis: a demonstration of secondary autoimmunity”, International Journal of Research in Dermatology, 5(4), pp. 882–884. doi: 10.18203/issn.2455-4529.IntJResDermatol20194687.